Cycloheximide
Specifications
66-81-9CAS Number
200-636-0EC Number
4-[(2R)-2-[(1S,3S,5S)-3,5-dimethyl-2-oxocyclohexyl]-2-hydroxyethyl]piperidine-2,6-dioneIUPAC Name
C15H23NO4Chemical Formula
281.35 g/molMolecular Weight
cycloheximide; 66-81-9; ACTIDIONE; Cicloheximide; NARAMYCIN A; Actidion; Hizarocin; Naramycin; Kaken; Acti-Aid; Actidone; Neocycloheximide; Cicloheximida; Actispray; Acti-Dione; Actidione PM; Cicloheximidum; NSC-185; Actidione BR; Actidione TGF; U-4527; Aktidion; NSC 185; 4-[(2R)-2-[(1S,3S,5S)-3,5-Dimethyl-2-oxocyclohexyl]-2-hydroxyethyl]piperidine-2,6-dione; DTXSID6024882; (-)-Cycloheximide; NM-MCD 80; CBC 500046; U 4527; 3-((R)-2-((1S,3S,5S)-3,5-Dimethyl-2-oxocyclohexyl)-2-hydroxyethyl)glutarimide; 4-{(2R)-2-[(1S,3S,5S)-3,5-dimethyl-2-oxocyclohexyl]-2-hydroxyethyl}piperidine-2,6-dione; 3-(2-(3,5-Dimethyl-2-oxocyclohexyl)-2-hydroxyethyl)glutarimide; beta-(2-(3,5-Dimethyl-2-oxocyclohexyl)-2-hydroxyethyl)glutarimide; DTXCID204882; 2,6-Piperidinedione, 4-(2-(3,5-dimethyl-2-oxocyclohexyl)-2-hydroxyethyl)-, (1S-(1alpha(S*),3alpha,5beta))-; CHEBI:27641; 3-[2-(3,5-Dimethyl-2-oxocyclohexyl)-2-hydroxyethyl]glutarimide; 98600C0908; 2,6-Piperidinedione, 4-((2R)-2-((1S,3S,5S)-3,5-dimethyl-2-oxocyclohexyl)-2-hydroxyethyl)-; 2,6-Piperidinedione, 4-[(2R)-2-[(1S,3S,5S)-3,5-dimethyl-2-oxocyclohexyl]-2-hydroxyethyl]-; 3-[(R)-2-[(1S,3S,5S)-3,5-Dimethyl-2-oxocyclohexyl]-2-hydroxyethyl]glutarimide; 4-((2R)-2-((1S,3S,5S)-3,5-DIMETHYL-2-OXOCYCLOHEXYL)-2-HYDROXYETHYL)PIPERIDINE-2,6-DIONE; RefChem:129667; 200-636-0; NSC-171; Cycloheximid; Zykloheximid; Cycloheximide [USAN]; Acti-dione BR; NSC185; Cicloheximide [INN]; TCMDC-125838; MFCD00082346; TZA; Cyclohexamide; 4-[(2R)-2-[(1S,3S,5S)-3,5-dimethyl-2-oxo-cyclohexyl]-2-hydroxy-ethyl]piperidine-2,6-dione; CHEMBL123292; GNF-PF-5118; 3-(2R)-2-((1S,3S,5S)-3,5-Dimethyl-2-oxocyclohexyl)-2-hydroxyethylglutarimide; Cicloheximide (INN); (1S-(1alpha(S*),3alpha,5beta))-4-(2-(3,5-Dimethyl-2-oxo-cyclohexyl))-2-hydroxyethyl-2,6-piperidinedione; CX; Cycloheximide (USAN); 4-((R)-2-((1S,3S,5S)-3,5-Dimethyl-2-oxocyclohexyl)-2-hydroxyethyl)piperidine-2,6-dione; Aktidion [Czech]; Cyclohemimide; Caswell No. 270A; .beta.-[2-(3,5-Dimethyl-2-oxocyclohexyl)-2-hydroxyethyl]glutarimide; 4-[2-(3,5-Dimethyl-2-oxo-cyclohexyl)-2-hydroxyethyl]-2,6-piperidinedione; Acti-dione PM; Acti-dione TGF; Cicloheximidum [INN-Latin]; Cicloheximida [INN-Spanish]; 4-[(2R)-2-((1S,3S,5S)-3,5-dimethyl-2-oxocyclohexyl)-2-hydroxyethyl]azaperhydro ine-2,6-dione; SMR000686067; CCRIS 937; Actidione;Naramycin A;CHX; HSDB 1552; SR-01000597484; SR-05000001596; EINECS 200-636-0; Cycloheximide [BSI:ISO]; EPA Pesticide Chemical Code 043401; BRN 0088868; Actidione;; AI3-15541; Naramycin;; Naramycin A.; CAS-66-81-9; NCGC00024910-01; Acti-Aid;; Prestwick_976; UNII-98600C0908; Spectrum_001344; FT 3422-2; Prestwick0_000790; Prestwick1_000790; Prestwick2_000790; Prestwick3_000790; Spectrum2_000900; Spectrum3_001510; Spectrum4_000914; Spectrum5_001635; CYCLOHEXIMIDE [MI]; CYCLOHEXIMIDE [ISO]; cid_6197; 4-((2R)-2-((1S,3S,5S)-(3,5-Dimethyl-2-oxocyclohexyl))-2-hydroxyethyl)piperidine-2,6-dione; CYCLOHEXIMIDE [HSDB]; SCHEMBL26617; BSPBio_000900; BSPBio_003159; KBioGR_001408; KBioSS_001824; 5-21-13-00434 (Beilstein Handbook Reference); ksc-8-190; MLS001055333; MLS002154001; CICLOHEXIMIDE [MART.]; DivK1c_000050; SPECTRUM1502112; SPBio_000720; SPBio_002839; 4-[2-(3,6-piperidinedione; BPBio1_000990; GTPL5433; orb1941022; orb2567338; HMS500C12; KBio1_000050; KBio2_001824; KBio2_004392; KBio2_006960; KBio3_002659; NINDS_000050; GLXC-10322; HMS1570M22; HMS1921L04; HMS2092D10; HMS2097M22; HMS3714M22; KUC105858N; Pharmakon1600-01502112; Cycloheximide, Streptomyces griseus; 2,6-PIPERIDINEDIONE, 4-(2-(3,5-DIMETHYL-2-OXOCYCLOHEXYL)-2-HYDROXYETHYL)-, (1S-(1.ALPHA.(S*),3.ALPHA.,5.BETA.))-; MSK21224; Tox21_113580; Tox21_201158; Tox21_303652; BDBM50080528; CCG-39902; Cycloheximide, >=93.0% (HPLC); HB2904; NSC758187; SBB005972; AKOS024282670; Tox21_113580_1; CS-4985; EBC-436073; MSK21224-1000M; NSC-758187; IDI1_000050; NCGC00017363-05; NCGC00017363-06; NCGC00017363-07; NCGC00017363-08; NCGC00017363-10; NCGC00017363-18; NCGC00017363-30; NCGC00024910-02; NCGC00024910-03; NCGC00024910-04; NCGC00024910-05; NCGC00024910-06; NCGC00169964-05; NCGC00257430-01; NCGC00258710-01; AC-35130; AC172520; AS-14624; BP-12396; HY-12320; NCI60_001540; ST057527; SBI-0051732.P002; WLN: T6VMVTJ E1YQ- BL6VTJ D1 F1; C9709; Cycloheximide 100 microg/mL in Acetonitrile; NS00004971; Cycloheximide, from microbial, >=94% (TLC); C-9217; C06685; Cycloheximide Solution in Methanol, 1000_g/mL; D03625; M01527; AB00052279_08; Cycloheximide, PESTANAL(R), analytical standard; Cycloheximide, Biotechnology Performance Certified; Q412895; Cycloheximide, Antibiotic for Culture Media Use Only; SR-01000597484-1; SR-01000597484-4; SR-05000001596-1; SR-05000001596-3; SR-05000001596-4; BRD-K36055864-001-05-1; BRD-K36055864-001-07-7; BRD-K36055864-001-09-3; BRD-K36055864-001-16-8; BRD-K36055864-001-19-2; BRD-K36055864-001-20-0; Cycloheximide - Antibiotic for Culture Media Use Only; 2,6-Piperidinedione, 4-[2-(3,5-dimethyl-2-oxocyclohex-1-yl)-2-hydroxy]ethyl-; [1S-[1.alpha.(S*),3.alpha.,5.beta.]]-4-[2-(3,5-Dimethyl-2-oxocyclohexyl)-2-hydroxyethyl]-2,6-piperidinedione; 1154-57-0; 2, 4-[2-(3,5-dimethyl-2-oxocyclohexyl)-2-hydroxyethyl]-, [1S-[1.alpha.(S*),3.alpha.,5.beta.]]-; 4-((2R)-2-((1S,3S,5S)-3,5-DIMETHYL-2-OXOCYCLOHEXYL)-2-HYDROXYETHYL)-2,6-PIPERIDINEDIONE; 4-[(2R)-2-[(1S,3S,5R)-3,5-dimethyl-2-oxo-cyclohexyl]-2-hydroxy-ethyl]piperidine-2,6-dione; 4630-75-5Synonyms
